Myofunctional Therapy in Facial Palsy

University of Sao Paulo General Hospital

Status: Completed

Conditions: Facial Paralysis

Treatments: Drug: Botulinum Toxin Type A; Procedure: myofunctional therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00989209

CAPPesq 890/04

Details and patient eligibility

About

Objective: Quantify the benefits of myofunctional therapy associated to botulinum toxin injection in patients with long standing facial unilateral palsy.

Full description

Twenty-five patients with long standing facial palsy were studied; all had been previously treated for facial reanimation. Patients were randomly divided in two groups; Group A did the myofunctional therapy sessions with the speech therapist before the botulinum toxin injection, while the participants of Group B did the myofunctional therapy after it.

Enrollment: 25 patients

Sex: All

Ages: 16 to 62 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• facial paralysis with more than 2 years elapsed since the onset of symptoms
• surgically treated for reanimation at least 12 months before
• static and/or dynamic facial asymmetry causing aesthetic concern

Exclusion criteria

• spastic paralysis
• serious systemic or neuromuscular diseases
• cognition impairment
• pregnant women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

25 participants in 2 patient groups

A: myofunctional prior to botulinum

Active Comparator group

Description:

All the facial paralysis patients received treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol. To the participants of Group A, botulinum toxin was applied after myofunctional therapy.

Treatment:

Procedure: myofunctional therapy

Drug: Botulinum Toxin Type A

B: myofunctional after botulinum

Active Comparator group

Description:

All the facial paralysis patients received treatment with botulinum toxin type A to the non-paralyzed side, according to the Institution Protocol. To the participants of Group B, botulinum toxin was applied before myofunctional therapy.

Treatment:

Procedure: myofunctional therapy

Drug: Botulinum Toxin Type A